Servicio de Información Comunitario sobre Investigación y Desarrollo - CORDIS

CORDIS reúne toda la información sobre los proyectos financiados por Horizonte 2020 , y ahora también resúmenes de los informes relacionados. Se puede descargar toda la documentación de estos proyectos en el Portal de datos abiertos de la UE .

My refinements


Download results of this page


Restringir por:

Tipo de contenido

Proyecto (42)

Advanced search

Búsqueda de proyectos y resultados

Results 1 - 10 of 42
Results/page:
12 3 4 5 > 
Validation of diagnostic and/or prognostic miRNAs in triple-negative breast cancer
ID: 663062
Fecha de inicio: 2015-01-01, Fecha de finalización: 2015-06-30
Multiplicom will draft a business plan that is composed of the following parts:(i) selection of miRNAs for which there is substantial scientific evidence that such may be important for the diagnosis, treatment and/or prognosis of triple-negative breast cancer (“TNBC”)...
Programme: H2020-EU.3.1.3.
Record Number: 196226
Last updated on: 2015-03-25
Development of DIALIVE, a novel Liver Dialysis Device for the treatment of patients with Acute on Chronic Liver Failure (ACLF)
ID: 733057
Fecha de inicio: 2017-01-01, Fecha de finalización: 2020-09-30
Liver disease incidence is increasing and about 170K patients die from liver failure each year in Europe. In liver failure, the accumulation of protein bound toxins and increased susceptibility to infection cause multiorgan failure and death. Liver transplantation is the only...
Programme: H2020-EU.3.1.3.
Record Number: 207215
Last updated on: 2017-08-04
SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma – a rare hematologic disease
ID: 754658
Fecha de inicio: 2018-01-01, Fecha de finalización: 2022-04-30
CARAMBA is proposing to use the revolutionary CAR-T cell technology to tackle multiple myeloma, a rare and incurable hematologic malignancy. Myeloma is associated with a substantial socioeconomic burden and there is a strong demand by patients, their families and caregivers...
Programme: H2020-EU.3.1.3.
Record Number: 216603
Last updated on: 2018-08-07
ERA-NET for establishing synergies between the Joint Programming on Neurodegenerative Diseases Research and Horizon 2020
ID: 643417
Fecha de inicio: 2015-01-01, Fecha de finalización: 2019-12-31
Over 12 million people in Europe suffer from neurodegenerative diseases (ND), yet treatments that prevent or stop the progression of neurodegeneration are still lacking. Tackling this grand challenge requires enhanced coordination of national efforts to accelerate discovery...
Programme: H2020-EU.3.1.3.
Record Number: 194063
Last updated on: 2017-08-22
PREvention of Complications to Improve OUtcome in elderly patients with acute Stroke
ID: 634809
Fecha de inicio: 2015-06-01, Fecha de finalización: 2020-05-31
Every year, 1.3 million Europeans have a stroke and one million ultimately die of stroke. One third of stroke patients remain dependent on the help of others. The annual costs for stroke care in Europe are estimated at € 64.1 billion. Stroke incidence increases almost...
Programme: H2020-EU.3.1.3.
Record Number: 193307
Last updated on: 2017-08-17
How to best meet the needs of people with dementia with severe behavioural disturbances. Toward a respectful and cost-effective model
ID: 779237
Fecha de inicio: 2018-01-01, Fecha de finalización: 2022-12-31
The RECAGE project will tackle one of the most challenging problem arising during the clinical course of dementia: the so-called Behavioural and Psychological Symptoms of Dementia (BPSD). The current state-of-the-art of the treatment of these symptoms is still unsatisfactory...
Programme: H2020-EU.3.1.3.
Record Number: 216103
Last updated on: 2018-06-28
Paediatric Inflammatory Bowel Diseases Network for Safety, Efficacy, Treatment and Quality improvement of care
ID: 668023
Fecha de inicio: 2016-01-01, Fecha de finalización: 2019-12-31
"The incidence of paediatric onset Inflammatory Bowel Diseases (PIBD) has risen dramatically in recent decades. Compared to adult forms, PIBD reflects a more severe disease, more often requiring aggressive treatment with immunomodulators, and thereby exposing children to a...
Programme: H2020-EU.3.1.3.
Record Number: 199745
Last updated on: 2017-03-27
Development of an innovative gene therapy platform to cure rare hereditary muscle disorders
ID: 667751
Fecha de inicio: 2016-01-01, Fecha de finalización: 2019-12-31
The objective of MYOCURE is to develop an innovative gene therapy platform to cure rare hereditary muscle disorders, specifically focusing on myotubular myopathy (MTM) and glycogen storage disorder (GSD) type II. These are attractive diseases for gene therapy since they...
Programme: H2020-EU.3.1.3.
Record Number: 199738
Last updated on: 2016-11-29
Randomized, Comparison Of Risk-Stratified versus Standard Breast Cancer Screening In European Women Aged 40-74
ID: 755394
Fecha de inicio: 2018-01-01, Fecha de finalización: 2025-12-31
MyPeBS addresses the crucial and timely question of the future of breast cancer screening in Europe. Indeed current standard mammographic screening, with entry stratified by age alone, has recently been largely questioned. Despite a demonstrated mean 20% reduction in breast...
Programme: H2020-EU.3.1.3.
Record Number: 212694
Last updated on: 2018-01-23
Testing the value of a novel strategic approach and its cost efficacy to improve the poor outcomes in Cardiogenic Shock
ID: 754946
Fecha de inicio: 2018-01-01, Fecha de finalización: 2022-12-31
Heart attacks are common and can leave survivors suffering cardiogenic shock (CGS), with its extremely high risk of early death (42% versus 4% for non-CGS) and high incidence of chronic heart failure, with its associated socio-economic disease burden (ill-health, recurrent...
Programme: H2020-EU.3.1.3.
Record Number: 212681
Last updated on: 2018-01-23
12 3 4 5 > 
List retrieved on: 2018-08-22
Síganos en: RSS Facebook Twitter YouTube Gestionado por la Oficina de Publicaciones de la UE Arriba